ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN MYELODYSPLASIA

Citation
Dr. Hull et al., ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN MYELODYSPLASIA, Ulster medical journal, 65(1), 1996, pp. 55-57
Citations number
12
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
00416193
Volume
65
Issue
1
Year of publication
1996
Pages
55 - 57
Database
ISI
SICI code
0041-6193(1996)65:1<55:ACAIM>2.0.ZU;2-B
Abstract
Antibodies to neutrophil cytoplasmic antigens (ANCA) are good serologi cal markers for patients with mainly vasculitic conditions. Two main t ypes of ANCAs have been detected the first termed cytoplasmic antineut rophil cytoplasmic antibody (cANCA) are mainly associated with patient s with Wegener's granulomatosis, the other termed perinuclear antineut rophil cytoplasmic antibody (pANCA) are mainly associated with patient s with renal vasculitis, rheumatic and collagen disorders, These antib odies are against various constituents of neutrophil granules. In pati ents with myelodysplasia, defects in normal granulocyte development ar e seen. We report a series of twelve patients with myelodysplasia of w hom at least four showed a low titre and one a high titre of pANCA. Tw o orf these patients also had demonstrable activity against myeloperox idase (MPO). None of these patients had any evidence of systemic or cu taneous vasculitis or of any autoimmune disorder. There was no pANCA p ositivity in an age matched control group.